NASDAQ:PRAH - PRA Health Sciences Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $87.64 +0.39 (+0.45 %) (As of 05/23/2019 02:44 PM ET)Previous Close$87.25Today's Range$86.26 - $88.0452-Week Range$80.28 - $121.98Volume22,142 shsAverage Volume658,680 shsMarket Capitalization$5.75 billionP/E Ratio22.26Dividend YieldN/ABeta1.01 ProfileAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email PRA Health Sciences, Inc., a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. The company operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services. It also provides strategic solutions, such as embedded, functional services provider, staff augmentation, and custom-built development solutions, as well as commercialization services; and early development services for Phase I and Phase IIa studies, and bioanalytical analysis. The Data Solutions segment offers data, analytics, technology, and consulting solutions to the life sciences market. Its services include market intelligence services, such as targeting and compensation, and pharmaceutical audit suite services; consulting and services comprising brand analytics, managed markets, commercial effectiveness, and scientific studies/clinical hubs; and technology-enabled products and services. PRA Health Sciences, Inc. conducts clinical trials in the areas of pharmaceutical development, including oncology, immunology, central nervous system, inflammation, respiratory, cardio metabolic, and infectious diseases. The company was formerly known as PRA Global Holdings, Inc. and changed its name to PRA Health Sciences, Inc. in July 2014. PRA Health Sciences, Inc. was founded in 1976 and is headquartered in Raleigh, North Carolina. Receive PRAH News and Ratings via Email Sign-up to receive the latest news and ratings for PRAH and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Commercial physical research Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:PRAH Previous Symbol CUSIPN/A CIK1613859 Webhttp://www.prahs.com/ Phone919-786-8200Debt Debt-to-Equity Ratio0.97 Current Ratio0.90 Quick Ratio0.90Price-To-Earnings Trailing P/E Ratio22.26 Forward P/E Ratio18.93 P/E Growth1.16 Sales & Book Value Annual Sales$2.87 billion Price / Sales2.00 Cash Flow$6.0192 per share Price / Cash Flow14.56 Book Value$16.98 per share Price / Book5.16Profitability EPS (Most Recent Fiscal Year)$3.93 Net Income$153.90 million Net Margins5.50% Return on Equity26.87% Return on Assets8.39%Miscellaneous Employees16,400 Outstanding Shares65,660,000Market Cap$5.75 billion Next Earnings Date8/7/2019 (Estimated) OptionableOptionable PRA Health Sciences (NASDAQ:PRAH) Frequently Asked Questions What is PRA Health Sciences' stock symbol? PRA Health Sciences trades on the NASDAQ under the ticker symbol "PRAH." How were PRA Health Sciences' earnings last quarter? PRA Health Sciences Inc (NASDAQ:PRAH) released its quarterly earnings data on Wednesday, February, 27th. The medical research company reported $1.21 EPS for the quarter, topping analysts' consensus estimates of $1.18 by $0.03. The medical research company had revenue of $729.65 million for the quarter, compared to the consensus estimate of $750.67 million. PRA Health Sciences had a net margin of 5.50% and a return on equity of 26.87%. View PRA Health Sciences' Earnings History. When is PRA Health Sciences' next earnings date? PRA Health Sciences is scheduled to release their next quarterly earnings announcement on Wednesday, August 7th 2019. View Earnings Estimates for PRA Health Sciences. What guidance has PRA Health Sciences issued on next quarter's earnings? PRA Health Sciences issued an update on its FY19 earnings guidance on Wednesday, May, 1st. The company provided EPS guidance of $4.93-$5.08 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.02. The company issued revenue guidance of $3.09-$3.20 billion, compared to the consensus revenue estimate of $3.13 billion. What price target have analysts set for PRAH? 9 analysts have issued 1 year target prices for PRA Health Sciences' stock. Their predictions range from $100.00 to $122.00. On average, they expect PRA Health Sciences' stock price to reach $114.25 in the next twelve months. This suggests a possible upside of 30.4% from the stock's current price. View Analyst Price Targets for PRA Health Sciences. What is the consensus analysts' recommendation for PRA Health Sciences? 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PRA Health Sciences in the last year. There are currently 4 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for PRA Health Sciences. Has PRA Health Sciences been receiving favorable news coverage? Press coverage about PRAH stock has trended somewhat positive on Thursday, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. PRA Health Sciences earned a daily sentiment score of 0.7 on InfoTrie's scale. They also assigned news stories about the medical research company a news buzz of 7.0 out of 10, meaning that recent press coverage is likely to have an impact on the stock's share price in the immediate future. Who are some of PRA Health Sciences' key competitors? Some companies that are related to PRA Health Sciences include Incyte (INCY), EXACT Sciences (EXAS), Icon (ICLR), Charles River Laboratories Intl. (CRL), Exelixis (EXEL), Syneos Health (SYNH), BTG (BTGGF), Medpace (MEDP), Intrexon (XON), Geovax Labs (GOVX), Sorrento Therapeutics (SRNE), Eloxx Pharmaceuticals (ELOX), STARPHARMA HOLD/S (SPHRY), Anavex Life Sciences (AVXL) and Pieris Pharmaceuticals (PIRS). What other stocks do shareholders of PRA Health Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other PRA Health Sciences investors own include Mattel (MAT), Ultra Clean (UCTT), General Electric (GE), Twitter (TWTR), US Foods (USFD), American National BankShares (AMNB), Enterprise Bancorp (EBTC), New York Times (NYT), Alibaba Group (BABA) and General Motors (GM). Who are PRA Health Sciences' key executives? PRA Health Sciences' management team includes the folowing people: Mr. Colin Shannon, Chairman, CEO & Pres (Age 60)Mr. Michael J. Bonello, Exec. VP, CFO & Corp. Sec. (Age 49)Mr. Kent Thoelke, Exec. VP & Chief Scientific OfficerMr. Thomas Byrne, VP of Legal AffairsChristine Rogers, Director of PR & Corp. Communications When did PRA Health Sciences IPO? (PRAH) raised $306 million in an IPO on Thursday, November 13th 2014. The company issued 17,000,000 shares at a price of $18.00 per share. Jefferies, Citigroup, KKR, UBS Investment Bank, Credit Suisse and Wells Fargo Securities served as the underwriters for the IPO and Baird and William Blair were co-managers. Who are PRA Health Sciences' major shareholders? PRA Health Sciences' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (9.46%), Wellington Management Group LLP (4.40%), FMR LLC (4.39%), AQR Capital Management LLC (2.78%), Frontier Capital Management Co. LLC (1.37%) and Eagle Asset Management Inc. (1.35%). Company insiders that own PRA Health Sciences stock include Colin Shannon, David W Dockhorn, Linda Baddour, Matthew P Young and Pra Investors LP Kkr. View Institutional Ownership Trends for PRA Health Sciences. Which major investors are selling PRA Health Sciences stock? PRAH stock was sold by a variety of institutional investors in the last quarter, including Jennison Associates LLC, Eagle Asset Management Inc., First Trust Advisors LP, Carillon Tower Advisers Inc., Goldman Sachs Group Inc., Swedbank, Pendal Group Ltd and Wellington Management Group LLP. View Insider Buying and Selling for PRA Health Sciences. Which major investors are buying PRA Health Sciences stock? PRAH stock was acquired by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, FMR LLC, Strs Ohio, Virginia Retirement Systems ET AL, Voya Investment Management LLC, Natixis, Morgan Stanley and Loomis Sayles & Co. L P. View Insider Buying and Selling for PRA Health Sciences. How do I buy shares of PRA Health Sciences? Shares of PRAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is PRA Health Sciences' stock price today? One share of PRAH stock can currently be purchased for approximately $87.64. How big of a company is PRA Health Sciences? PRA Health Sciences has a market capitalization of $5.75 billion and generates $2.87 billion in revenue each year. The medical research company earns $153.90 million in net income (profit) each year or $3.93 on an earnings per share basis. PRA Health Sciences employs 16,400 workers across the globe. What is PRA Health Sciences' official website? The official website for PRA Health Sciences is http://www.prahs.com/. How can I contact PRA Health Sciences? PRA Health Sciences' mailing address is 4130 PARKLAKE AVENUE SUITE 400, RALEIGH NC, 27612. The medical research company can be reached via phone at 919-786-8200 or via email at [email protected] MarketBeat Community Rating for PRA Health Sciences (NASDAQ PRAH)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 299 (Vote Outperform)Underperform Votes: 262 (Vote Underperform)Total Votes: 561MarketBeat's community ratings are surveys of what our community members think about PRA Health Sciences and other stocks. Vote "Outperform" if you believe PRAH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRAH will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/23/2019 by MarketBeat.com StaffFeatured Article: Forex Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.